BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2866419)

  • 21. Natural antibodies to simian type-C viruses and human retrovirus HTLV in patients with lymphoid malignancies.
    Tóth FD; Szabó B; Váczi L; Kiss A; Kovács I; Rák K; Kiss C; Gallo RC
    Acta Microbiol Hung; 1984; 31(4):387-92. PubMed ID: 6100223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into a chronic lymphocytic leukemia.
    Gale RP; Rai KR
    Leukemia; 1987 Sep; 1(9):677-9. PubMed ID: 2823026
    [No Abstract]   [Full Text] [Related]  

  • 23. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
    Lal RB; Rudolph DL; Schmid DS; Lairmore MD
    Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High incidence of human type-C retrovirus (HTLV) in family members of a HTLV-positive Japanese T-cell leukemia patient.
    Sarin PS; Aoki T; Shibata A; Ohnishi Y; Aoyagi Y; Miyakoshi H; Emura I; Kalyanaraman VS; Robert-Guroff M; Popovic M; Sarngadharan M; Nowell PC; Gallo RC
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2370-4. PubMed ID: 6300913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of FAB classification of acute leukemia---its management, and chromosome analysis].
    Kamada S; Dohi H
    Rinsho Ketsueki; 1982 Jul; 23(7):1055-60. PubMed ID: 6958890
    [No Abstract]   [Full Text] [Related]  

  • 26. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
    Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
    Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological findings associated with HTLV-III antibody positivity.
    Antonen J
    Ann Clin Res; 1985; 17(2):81-5. PubMed ID: 2994542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retroviruses and leukemia].
    Matutes E; Catovsky D
    Med Clin (Barc); 1984 Mar; 82(10):448-50. PubMed ID: 6325832
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical implications of anti-HTLV antibody titer, abnormal lymphocytes in HTLV carriers and HTLV genome negative adult T-cell leukemia-lymphoma.
    Shimoyama M; Seki S; Nagai M; Minato K; Kitamura T; Hoshino H; Miwa M; Tobinai K; Nagoshi H; Oosuga T
    Princess Takamatsu Symp; 1984; 15():71-6. PubMed ID: 6152761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [